Search Results - "Di Martino, M T"
-
1
Promises and challenges of MicroRNA-based treatment of multiple myeloma
Published in Current cancer drug targets (01-09-2012)“…MicroRNAs (miRNAs) recently emerged with a key role in multiple myeloma (MM) pathophysiology and are considered important regulators of MM cell growth and…”
Get more information
Journal Article -
2
Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma
Published in Current cancer drug targets (01-09-2012)“…Mouse models of multiple myeloma (MM) are basic tools for translational research and play a fundamental role in the development of new therapeutics against…”
Get more information
Journal Article -
3
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells
Published in Leukemia (01-04-2011)Get full text
Journal Article -
4
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
Published in Leukemia (01-11-2015)“…Interferon regulatory factor 4 (IRF4) is an attractive therapeutic target in multiple myeloma (MM). We here report that expression of IRF4 mRNA inversely…”
Get full text
Journal Article -
5
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells
Published in Leukemia (01-04-2018)“…Dendritic cells (DCs) have a key role in regulating tumor immunity, tumor cell growth and drug resistance. We hypothesized that multiple myeloma (MM) cells…”
Get full text
Journal Article -
6
Psychrophilic superoxide dismutase from Pseudoalteromonas haloplanktis: biochemical characterization and identification of a highly reactive cysteine residue
Published in Biochimie (01-10-2006)“…A psychrophilic superoxide dismutase (SOD) has been characterized from the Antarctic eubacterium Pseudoalteromonas haloplanktis ( Ph). PhSOD is a homodimeric…”
Get full text
Journal Article -
7
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
Published in Cell death & disease (01-11-2012)“…MicroRNAs (miRNAs) with tumor-suppressor potential might have therapeutic applications in multiple myeloma (MM) through the modulation of still undiscovered…”
Get full text
Journal Article -
8
Development and validation of a bioanalytical method for quantification of LNA-i-miR-221, a 13-mer oligonucleotide, in rat plasma using LC–MS/MS
Published in Journal of pharmaceutical and biomedical analysis (20-02-2018)“…•An ion-pair reversed-phase LC–MS/MS method for the determination of LNA-i-miR-221, a 13-mer oligonucleotide, in rat plasma was developed and…”
Get full text
Journal Article -
9
A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival
Published in Blood cancer journal (New York) (16-12-2016)“…Multiple myeloma (MM) is closely dependent on cross-talk between malignant plasma cells and cellular components of the inflammatory/immunosuppressive bone…”
Get full text
Journal Article -
10
P341: A NOVEL BISPECIFIC T CELL ENGAGER (UMG2‐CD3) IS EFFECTIVE AGAINST CORTICAL‐DERIVED ACUTE LYMPHOBLASTIC LEUKEMIA
Published in HemaSphere (23-06-2022)Get full text
Journal Article -
11
-
12
Correction: Targeting miR21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth
Published in Clinical cancer research (15-10-2014)Get full text
Journal Article -
13
From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario
Published in Current drug targets (01-09-2013)“…The progress in the understanding of biological events underlying multiple myeloma (MM) development and progression has allowed the design of molecularly…”
Get more information
Journal Article -
14
-
15
Differential transcriptional response to cisplatinum in BRCA1-defective versus BRCA1-reconstituted breast cancer cells by microarrays
Published in Cancer research (Chicago, Ill.) (15-01-2009)“…Abstract Abstract #5062 BRCA1-related breast cancer represents a distinct clinical entity characterized by basal-like molecular phenotype. HCC1937 is a…”
Get full text
Journal Article -
16
EDTA is essential to recover lead from dried blood spots on filter paper
Published in Clinica chimica acta (01-12-2004)“…Residual dried blood spots (DBSs) on filter paper from neonatal screening have been proposed as samples for population survey of lead contamination. We have…”
Get full text
Journal Article -
17
Areas in Calabria with an elevated incidence of congenital hypothyroidism and iodine content of drinking water
Published in Annali dell'Istituto superiore di sanità (1998)“…The screening of 128,442 newborns, carried out in our laboratory from 1/1/1991 to 31/12/1996, detected 51 cases of congenital hypothyroidism (CH). Due to a 98%…”
Get more information
Journal Article